Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.US-based biotechnology company Sangamo BioSciences has reported a consolidated net loss of $6.83 million, or $0.17 per share, for the first quarter ended March 31, 2009, compared to a net loss of $7.97 million, or $0.20 per share, for the first quarter ended March 31, 2008.
Subscribe to our email newsletter
Revenues for the first quarter of 2009 were $3.16 million, compared to $2.76 million for the same period in 2008. First quarter 2009 revenues were primarily from Sangamo’s agreements with Dow AgroSciences and Sigma-Aldrich and enabling technology agreements.
Net interest and other income was $0.2 million for the first quarter of 2009, compared to $0.8 million for the same period in 2008. The decrease was due to lower average investment balances and lower interest rates, the company said.